Ipratropium and lung health study.
Lanes
Stephan
S
Golisch
Wolfgang
W
Mikl
Jaromir
J
D000280:Administration, Inhalation; D000367:Age Factors; D000368:Aged; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage* / Q000009:adverse effects; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013617:Tachycardia, Supraventricular / Q000453:epidemiology / Q000401:mortality; D013997:Time Factors
D001993:Bronchodilator Agents; D009241:Ipratropium